Results 211 to 220 of about 8,428 (249)

Mesalamine

2021
openaire   +1 more source

Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease

Inflammatory Bowel Diseases, 2022
Yoichi Kakuta, Tetsuya Takagawa, Hiroyuki Hanai   +2 more
exaly  

Mesalamine

2001
A DASH, H BNTTAIN
openaire   +2 more sources

Pancreatitis induced by mesalamine.

The Netherlands journal of medicine, 1992
Sulphasalazine is an active agent in the treatment of chronic inflammatory bowel disease, but there are a number of well-known side effects, including pancreatitis. The newer 5-ASA agents are thought to be equally effective but less toxic. Here we describe a patient who developed a pancreatitis due to mesalamine; this was confirmed at rechallenge.
F, Erdkamp, M, Houben, E, Ackerman, W, Breed, J, van Spreeuwel   +4 more
openaire   +1 more source

Mesalamine

2017
openaire   +2 more sources

Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis

Journal of Clinical Biochemistry and Nutrition, 2022
Katsura Mizushima, Kohei Asaeda, Yuma Hotta   +2 more
exaly  

Mesalamine

2020
openaire   +1 more source

Peri-myocarditis caused by topical rectal mesalamine

Clinical Journal of Gastroenterology, 2021
Benjamin Koslowsky, Amir Orlev
exaly  

Headache During Mesalamine Therapy: A Case Report of Mesalamine-Induced Pseudotumor Cerebri

Journal of Pediatric Gastroenterology and Nutrition, 2001
D, Rottembourg, F, Labarthe, S, Arsene, A P, Jonville-Béra, C, Maurage, J C, Rolland   +5 more
openaire   +2 more sources

Mesalamine in the treatment and maintenance of remission of ulcerative colitis

Expert Review of Clinical Pharmacology, 2012
Alan C Moss
exaly